Omar, Minhadz D.

HRN: 23-30-03  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2023
CEFTRIAXONE 1G (VIAL)
07/09/2023
07/15/2023
IV DRIP
540mg
Q24
Pcap Moderate
Waiting Final Action 
07/12/2023
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
07/12/2023
07/18/2023
PO
1.9 Ml
OD
Pcap C
Waiting Final Action 
07/18/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/18/2023
07/25/2023
IVTT
400mg
Q6
PCAP
Waiting Final Action 
07/23/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/23/2023
07/30/2023
IV
54mg
Q8
AGE
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: